Treatment of Periorbital Vascularity, Erythema, and Hyperpigmentation.

Blepharoplasty Chemical peel Classification Laser Lightening topical Periorbital hyperpigmentation

Journal

Clinics in plastic surgery
ISSN: 1558-0504
Titre abrégé: Clin Plast Surg
Pays: United States
ID NLM: 0424767

Informations de publication

Date de publication:
Jul 2023
Historique:
medline: 15 5 2023
pubmed: 12 5 2023
entrez: 11 5 2023
Statut: ppublish

Résumé

Periorbital hyperpigmentation (POH) is a common aesthetic concern that impacts patients' emotional well-being and quality of life. POH can be difficult to manage as the etiology is often multifactorial or difficult to elucidate. An understanding of different contributing factors and ability to classify hyperpigmentation can aid in the management of POH. Classification of POH is divided into pigmented, vascular, structural, and mixed subtypes. A wide array of treatment options has been proposed belying the challenges inherent to improving POH. Modalities vary from topical therapies, chemical peels, dermal fillers, and lasers, to surgical intervention. Because POH can be multifactorial, successful management of POH will depend on elucidating the etiology and often requires a combination of therapies.

Identifiants

pubmed: 37169406
pii: S0094-1298(22)00119-5
doi: 10.1016/j.cps.2022.12.005
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

399-409

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Christen B Samaan (CB)

Department of Dermatology, Penn State Health, Milton S. Hershey Medical Center, 500 University Drive, HU 14, Hershey, PA 17033, USA.

Todd V Cartee (TV)

Department of Dermatology, Penn State Health, Milton S. Hershey Medical Center, 500 University Drive, HU 14, Hershey, PA 17033, USA. Electronic address: tcartee@pennstatehealth.psu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH